Why Biohaven Stock Crumbled On This Premium Deal With Pfizer

Why Biohaven Stock Crumbled On This Premium Deal With Pfizer

1 week from now

Nov 9, 2021  · Third-quarter sales also topped BHVN stock analysts' forecast for $125.8 million. Biohaven lost $1.91 per share, but that also beat forecasts for a per-share loss of $2.37. In the …

investors.com

Pfizer Completes Acquisition Of Biohaven Pharmaceuticals

1 week from now

Oct 3, 2022  · Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately …

pfizer.com

BHVN Stock Rockets: Pfizer Snaps Up Biohaven For Nearly $12 …

1 week from now

May 10, 2022  · Pfizer will pay $148.50 per share of BHVN stock and settle Biohaven's third-party debt. The terms value Biohaven stock at a 33% premium to the average volume-weighted …

investors.com

Two Years After Selling Its Migraine Assets To Pfizer In $13B Deal, …

1 week from now

Oct 28, 2024  · Fast-forward to 2022, when pharmaceutical giant Pfizer Inc. completed its $11.6 billion acquisition of those migraine therapeutic assets, while also paying off Biohaven’s debt, …

hartfordbusiness.com

Biohaven (BHVN) Up On PFE's Buyout Offer, Q1 Loss Wider

1 week from now

May 11, 2022  · Pfizer will buy the remaining outstanding shares of Biohaven’s common stock at $148.50 each. The acquisition price represents a premium of 78.6% to BHVN’s closing price on May 10.

nasdaq.com

Pfizer Buys Its Way Into Migraine With $11.6B Biohaven Pharma ...

1 week from now

May 10, 2022  · According to terms of the deal, Pfizer will pay $148.50 cash for each share of Biohaven that it does not already own. That price is a 78.6% premium to Biohaven’s closing …

medcitynews.com

Pfizer To Buy Rest Of Biohaven For $11.6B - Fox Business

1 week from now

May 10, 2022  · Pfizer said it would pay $148.50 a share in cash for the Biohaven shares that it doesn't already own, a nearly 79% premium to Monday's closing price of $83.14 for the New …

foxbusiness.com

Pfizer To Buy Remaining Stake In Biohaven Pharma For $148.50

1 week from now

May 10, 2022  · Pfizer will also make payments at closing to settle Biohaven's third party debt and for the redemption of all outstanding shares of Biohaven's redeemable preferred stock. Under the deal terms ...

nasdaq.com

Pfizer To Acquire Biohaven In $11.6B Bet On Biotech's Migraine Drugs

1 week from now

May 10, 2022  · Dan Kitwood via Getty Images. Pfizer has agreed to acquire Biohaven Pharmaceuticals for $11.6 billion in a deal that turns an existing alliance on a fast-selling …

biopharmadive.com

Why Biohaven Pharmaceutical Stock Soared Today - Nasdaq

1 week from now

May 10, 2022  · Shares of Biohaven Pharmaceutical rocketed 68% on Tuesday after the biopharmaceutical company struck a deal to be acquired by Pfizer. So what. Biohaven is a …

nasdaq.com

Pfizer To Buy Biohaven Pharmaceutical In $11.6 Bln Deal

1 week from now

May 10, 2022  · A dds details on deal terms, ... Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6% premium to …

nasdaq.com

Pfizer's $11.6 Bln Biohaven Buy Could Spark More Biotech Deals

1 week from now

May 11, 2022  · Pfizer offered a 78.6% premium, or $148.50 per Biohaven share, but that was below the $151.51 price Biohaven shares traded at in October before the months-long selloff …

reuters.com

Cash-rich Pfizer To Pay $11.6 Billion For Biohaven In Biggest Deal ...

1 week from now

May 10, 2022  · Pfizer will pay $11.6 billion to buy migraine pill maker Biohaven Pharmaceutical, marking the biggest deal by the cash-rich drugmaker since 2016 to beef up its portfolio ahead …

cnbc.com

Pfizer Adds Migraine Drugs With Planned $11.6B Biohaven …

1 week from now

May 10, 2022  · 33% premium. Pfizer agreed to acquire all outstanding shares of Biohaven it does not already own for $148.50 per share cash, an approximately 33% premium to Biohaven’s …

genengnews.com

StockWatch: Biohaven, And Investors, Benefit From Pfizer Buying …

1 week from now

May 13, 2022  · Biohaven Pharmaceuticals investors roared their approval of Pfizer's plan to acquire the company for $11.6 billion by sending the company’s shares rocketing 68%.

genengnews.com